United States · FDA National Drug Code directory
CRYSVITA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42747-203_763f89b2-723c-410d-b3b6-cc001c16c3ca
- Product NDC
- 42747-203
- Form
- INJECTION
- Composition / generic term
- Burosumab
- Labeler
- Kyowa Kirin, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180418
- Source listing expiry
- 20271231
Source-listed ingredients
- BUROSUMAB — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (42747-203-01) / 1 mL in 1 VIAL, SINGLE-USE · 42747-203-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →